Ganesh S Palapattu, MD, FACS, FRCS(Glasg)

 profile-ganesh-palapattu-2019
George F and Sandy G Valassis Professor of Urology
Professor of Urology
Chair, Department of Urology
Interim Executive Vice President for Medical Affairs
Interim Chief Executive Officer, Medical School
Available to mentor
Ganesh S Palapattu, MD, FACS, FRCS(Glasg)
profile-ganesh-palapattu-2019
Professor
  • Center Memberships
  • Recent Publications

  • Manage Your Profile

    • Center Memberships
    • Center Member
      Global REACH
    • Center Member
      MM-PKUHSC Joint Institute
    • Center Member
      Rogel Cancer Center

    Recent Publications

     See All Publications
    • Journal Article
      IP31-02 NON-INVASIVE URINE TEST PREDICTS THE NEED FOR BIOPSY IN PATIENTS ON ACTIVE SURVEILLANCE FOR PROSTATE CANCER: PROSPECTIVE MULTISITE VALIDATION AND COMPARISON WITH MRI
      Britton CJ, Meyers J, Moore B, Chevli K, Rayford W, Gadzinski AJ, Joseph JV, Patel P, Kasraeian A, Sethi PS, Robinson H, Assani KJ, Pierce JJ, Scarpato KR, Moses KA, Barocas DA, Chang SS, Penson DF, Ross A, Zhang Y, Siddiqui J, Singhal U, Salami SS, Morgan TM, Palapattu GS, Wei JT, Cao JT, Bala V, Oh Y, Heaton S, Zheng Y, Chinnaiyan AM, Tosoian JJ. Journal of Urology, 2026 Apr 30; 215 (5S): e660 DOI:10.1097/01.ju.0001191468.48904.a0.02
    • Journal Article
      IP49-13 MOLECULAR MARGIN EXTENT IN PROSTATE CANCER VARIES BY ERG FUSION STATUS
      Nallandhighal S, Monda S, Mannon R, Mahapatra S, Bahar P, Duan Z, Huang S, Wood A, George A, Mehra R, Chinnaiyan A, Salami S, Zaslavsky A, Palapattu G. Journal of Urology, 2026 Apr 30; 215 (5S): e1019 DOI:10.1097/01.ju.0001191580.27461.8d.13
    • Journal Article
      Non-Invasive Urine Test Predicts Grade Group Upgrading in Patients on Active Surveillance for Prostate Cancer: Multisite Validation and Comparison with MRI.
      Tosoian JJ, Meyers JI, Moore B, Britton CJ, Chevli K, Rayford W, Gadzinski AJ, Joseph JV, Patel P, Kasraeian A, Sethi PS, Robinson HS, Assani KD, Rings V, Pierce J, Scarpato KR, Moses KA, Barocas DA, Chang SS, Penson DF, Sanda MG, Ross AE, Cooperberg MR, Salari K, Liss M, Zhang Y, Siddiqui J, Singhal U, Salami SS, Morgan TM, Palapattu GS, Wei JT, Cao J, Bala V, Oh Y, Heaton S, Zheng Y, Chinnaiyan AM. J Urol, 2026 Apr 28; 101097JU0000000000005095 DOI:10.1097/JU.0000000000005095
      PMID: 42048777
    • Journal Article
      Understanding randomized controlled trial generalizability through an embedded molecular diagnostics trial.
      Lewicki P, Srivastava A, Jiang R, Johnson A, Ghani K, Ginsburg K, Borza T, Stensland K, Salami SS, Davicioni E, Dunn RL, Daignault-Newton S, Palapattu GS, Spratt DE, Cher M, Schipper M, Dess RT, Morgan TM, Singhal U. JNCI Cancer Spectr, 2026 Apr 24; DOI:10.1093/jncics/pkag040
      PMID: 42026952
    • Journal Article
      A0002 Long-term effects of enzalutamide and abiraterone acetate in men with metastatic castration-resistant prostate cancer: Results from a randomised clinical trial (HEAT)
      Kvorning TK, Fode M, S⊘nksen J, Bisbjerg R, Lindberg H, Palapattu G, Bratt O, Østergren PB. European Urology, 2026 Feb 15; 89: s1 - s2. DOI:10.1016/s0302-2838(26)00070-9
    • Proceeding / Abstract / Poster
      Physician perspectives on the implementability of a cardiovascular risk score for prostate cancer: A PRISM-guided evaluation.
      Kunhiraman HH, Kruse-Diehr A, Koo P, Armstrong AJ, Swami U, Efstathiou E, Morgans AK, Alumkal JJ, Hahn AW, Palapattu GS, Beltran H, Bin Riaz I, Roy S, Moses KA, Esdaille AR, Harrison MR, Satkunasivam R, Klaassen Z, Agarwal N, Guha A. Journal of Clinical Oncology, 2026 Mar 4; 44 (7_suppl): 57 - 57. DOI:10.1200/jco.2026.44.7_suppl.57
    • Journal Article
      Molecular profiling of primary versus paired asynchronous metastatic clear cell renal cell carcinoma reveals heterogeneity in tumor immune microenvironment
      Cotta B, Nallandhighal S, Monda S, Knuth Z, Triner D, Zhang Y, Wang R, Su F, Kasputis A, Cao X, Udager A, Dhanasekaran SM, Palapattu GS, Mehra R, Cieslik MP, Morgan TM, Salami SS. Scientific Reports, 2026 Jan 28; 16 (1): 5473 DOI:10.1038/s41598-026-35021-7
      PMID: 41606069
    • Journal Article
      The Isolation and Characterization of Human Prostate Cancer Stem Cells
      Palapattu GS. 2017 Sep 15; DOI:10.21236/ada604404

    Featured News & Stories
    Department News

    U-M Awards Strategic Initiative Fund Grant to Diabetes Reprogramming Initiative Led by Dr. Ganesh Palapattu

    Dr. Ganesh Palapattu's Michigan Initiative to Reprogram Cells for Diabetes (MIRC-D) has been selected for funding through the University of Michigan's Strategic Initiative Fund, supporting innovative, multidisciplinary research aimed at transforming diabetes treatment.
         cup sample with orange top in front of toilet
    Health Lab

    Urine-based test detects aggressive prostate cancer

    Researchers at have validated a previously developed urine test, which can potentially bypass invasive procedures for prostate cancer detection among men who are unlikely to benefit. 
         Smiling seated portrait of Glenn and Trish Granger. They are both holding their dog, Max.
    Philanthropy News

    Granger family supports prostate cancer research with dedicated fund

    With the same high standards that drive their successful construction company, Glenn and Trish Granger approach philanthropy with a commitment to meaningful impact.